Cardioneuroablation for cardioinhibitory vasovagal syncope.
cardioinhibitory
cardioneuroablation
ganglionated plexi
high-density mapping
vasovagal syncope
Journal
Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
revised:
23
02
2021
received:
24
12
2020
accepted:
27
02
2021
pubmed:
16
4
2021
medline:
11
8
2021
entrez:
15
4
2021
Statut:
ppublish
Résumé
Cardioneuroablation (CNA) is an emerging technique being used to treat patients with cardioinhibitory vasovagal syncope (VVS). We describe a case of CNA in targeting atrial ganglionated plexi (GP) based upon anatomical landmarks and fractionated electrogram (EGM) localization in a patient with cardioinhibitory syncope. A 20-year-old healthy female presented with malignant VVS and symptomatic sinus pauses, with the longest detected at 10 s. She underwent acutely successful CNA with demonstration of vagal response (VR) noted after ablation of left sided GP, and tachycardia noted with right sided GP ablation. All GP sites were defined by anatomical landmarks and EGM analysis. By using the fractionation mapping software of Ensite Precision mapping system with high density mapping, fragmented EGMs were successfully detected in each GP site. One month after vagal denervation, there were no recurrent syncopal episodes or sinus pauses. Longer term follow-up with implantable loop recorder is planned. We performed CNA in a patient with VVS by utilizing a novel approach of combined use of high density mapping and fractionation mapping software. With this approach, we were able to detect fractionation in all GP sites and demonstrate acute VR. This workflow may allow for a new, standardized technique suitable for widespread use.
Sections du résumé
BACKGROUND
Cardioneuroablation (CNA) is an emerging technique being used to treat patients with cardioinhibitory vasovagal syncope (VVS). We describe a case of CNA in targeting atrial ganglionated plexi (GP) based upon anatomical landmarks and fractionated electrogram (EGM) localization in a patient with cardioinhibitory syncope.
CASE PRESENTATION
A 20-year-old healthy female presented with malignant VVS and symptomatic sinus pauses, with the longest detected at 10 s. She underwent acutely successful CNA with demonstration of vagal response (VR) noted after ablation of left sided GP, and tachycardia noted with right sided GP ablation. All GP sites were defined by anatomical landmarks and EGM analysis. By using the fractionation mapping software of Ensite Precision mapping system with high density mapping, fragmented EGMs were successfully detected in each GP site. One month after vagal denervation, there were no recurrent syncopal episodes or sinus pauses. Longer term follow-up with implantable loop recorder is planned.
CONCLUSION
We performed CNA in a patient with VVS by utilizing a novel approach of combined use of high density mapping and fractionation mapping software. With this approach, we were able to detect fractionation in all GP sites and demonstrate acute VR. This workflow may allow for a new, standardized technique suitable for widespread use.
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
1748-1753Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Shen WK, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2017;14(8):e218-e254.
Hu F, Zheng L, Liang E, et al. Right anterior ganglionated plexus: the primary target of cardioneuroablation? Heart Rhythm. 2019;16(10):1545-1551.
Lu Y, Wei W, Upadhyay G, Tung R Catheter-based cardio-neural ablation for refractory vasovagal syncope: first U.S. report. J Am Coll Cardiol Case Rep. 2020;8:1161-1165.
Aksu T, Guler TE, Bozyel S, Yalin K, Gopinathannair R Usefulness of post-procedural heart rate response to predict syncope recurrence or positive head up tilt table testing after cardioneuroablation. Europace. 2020;22(9):1320-1327.
Pachon M JC, Pachon M EI, Pachon MJC, et al. Cardioneuroablation-new treatment for neurocardiogenic syncope, functional AV block, and sinus dysfunction using catheter RF-ablation. Europace. 2005;7:1-13.
Aksu T, Yalin K, Gopinathannair R Fractionation mapping software to map ganglionated plexus sites during sinus rhythm. J Cardiovasc Electrophysiol. 2020;31(12):3326-3329.
Aksu T, Guler TE, Bozyel S, Yalin K Vagal responses during cardioneuroablation on different ganglionated plexi: Is there any role of ablation strategy? Int J Cardiol. 2020;304:50-55.
Pachon MEI, Pachon MJC, Higuti C, et al. Relation of fractionated atrial potentials with the vagal innervation evaluated by extracardiac vagal stimulation during cardioneuroablation. Circ Arrhythm Electrophysiol. 2020;13:302-313.
Pachon MJC, Pachon MEI, Pachon MJC, et al. A new treatment for atrial fibrillation based on spectral analysis to guide the RF-ablation catheter. Europace. 2004;6:590-601.
Lellouche N, Buch E, Celigoj A, et al. Functional characterization of atrial electrograms in sinus rhythm delineates sites of parasympathetic innervation in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol. 2007;50:1324-1331.
Stavrakis S, Nakagawa H, Po S, Scherlag B, Lazzara R, Jackman W The role of the autonomic ganglia in atrial fibrillation. JACC Clinical Electrophysiol. 2015;1:1-13.
Sun W, Zheng L, Qiao Y, et al. Catheter ablation as a treatment for vasovagal syncope: long-term outcome of endocardial autonomic modification of the left atrium. J Am Heart Assoc. 2016;5(7):e003471.